Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 0.745\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a. Cc1nn(Cc2ccccc2)c(C)c1C(=O)N1CCN(CC(=O)Nc2ccc(F)cc2)CC1
b. Cc1ccc(/C=N/N=C2/NC(=O)C(CC(=O)Nc3ccccc3)S2)o1
Answer: b. Cc1ccc(/C=N/N=C2/NC(=O)C(CC(=O)Nc3ccccc3)S2)o1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(/C=N/N=C2/NC(=O)C(CC(=O)Nc3ccccc3)S2)o1
Cc1ccc(/C=N/N=C2/NC(=O)C(CC(=O)Nc3ccccc3)S2)o1
2-[(2Z)-2-[(E)-(5-methylfuran-2-yl)methylidenehydrazinylidene]-4-oxo-1,3-thiazolidin-5-yl]-N-phenylacetamide